Psychedelic drug could lift spirits in final years
Symptom relief
Recruiting now
This phase 2 trial tests whether psilocybin therapy can reduce demoralization in adults with a life expectancy of two years or less. One hundred participants will receive either psilocybin or an active control (ketamine) in a triple-blind design. The goal is to see if this approa…
Phase: PHASE2 • Sponsor: Charles S. Grob, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC